Evolving Innovative Trial Design with Diverse Patient Populations to Optimize Clinical Development
Time: 11:00 am
day: Day 2 Stream 2 AM
Details:
- Designing a robust development program to accelerate drug development
- F1, F2, F3, F4: navigating diverse patient populations in clinical studies to optimize treatment
- Evaluating clinical development of EFX in Phase IIb and histological outcomes
